Beneficial effects of DAAs on cardiac function and structure in hepatitis C patients with low-moderate liver fibrosis.
Dalbeni A, Romano S, Bevilacqua M, Piccoli A, Imbalzano E, Mantovani A, Benati M, Montagnana M, Donato A, Torin G, Monaco C, Cattazzo F, Tagetti A, Paon V, Ieluzzi D, Iogna Prat L, Roccarina D, Ribichini F, Capra F, Minuz P, Fava C.
Dalbeni A, et al.
J Viral Hepat. 2020 Nov;27(11):1214-1221. doi: 10.1111/jvh.13355. Epub 2020 Aug 13.
J Viral Hepat. 2020.
PMID: 32593212